Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2006
02/15/2006CN1733803A Lung carcinoma early stage serum specific protein and its uses
02/15/2006CN1733800A Outer surface proteins, their genes, and their use
02/15/2006CN1733798A Hepatitis B virus surface L protein related peptide
02/15/2006CN1733752A Emblic leafflower fruit extract possessing anticancer, antibiotic actions and its manufacturing method of traditional Chinese medicine formulation
02/15/2006CN1733287A Proprietary Chinese traditional medicine with marked effect in treating hysteromyoma, process for preparing the same and quality controlling method thereof
02/15/2006CN1733273A Pulean pharmaceutical preparation, process for preparing the same and quality controlling method thereof
02/15/2006CN1733257A Chinese traditional medicine capsule for curing essential hypotension, process for preparing the same and quality controlling method thereof
02/15/2006CN1733256A Pill for expelling wind, eliminating dampness, dredging meridians, activating collaterals, dispelling cold and reliving pain and quality controlling method thereof
02/15/2006CN1733189A Technique for preparing Yueju capsule and quality control method
02/15/2006CN1733187A Method for controlling quality of medicine composition for curing traumatic injury
02/15/2006CN1733153A Chinese traditional medicine capsule for treating apoplexy, its preparation process and quality control method
02/15/2006CN1733139A Chinese traditional medicine preparation for nourishing yin and blood, its preparation process and quality control method
02/15/2006CN1733105A Preparation for treating gynecological disease, its preparation process and quality control method
02/15/2006CN1733007A Externally applied Chinese medicinal oil for treating skin sores and its quality control method
02/15/2006CN1242270C Biosensors and measurement method
02/15/2006CN1242269C Preparation of plastic micro-flow control chip with screen pores
02/15/2006CN1242268C Apparatus and method for in situ measuring of evaporation from a surface
02/15/2006CN1242267C Quality controlling method for Shenfu injection preparation
02/15/2006CN1242266C Smell measuring devices
02/15/2006CN1242262C Method for separating biological macromolecule by using two-dimensional or multi-dimensional capillary electrophoresis
02/15/2006CN1242256C Apparatus and methods for analyzing and improving agricultural products
02/15/2006CN1242253C Breathing gas sampler bag and gas measurer
02/15/2006CN1242071C Drum type technique for preparing biochip in micro array mode
02/15/2006CN1242070C Method for preparing point samples for micro array chip of compound
02/15/2006CN1242047C Method and device for creating micro-arrays
02/15/2006CN1241944C Antibody againts 'alpha'-chain of human interleukin 5 receptor
02/15/2006CN1241678C Transparent model alloy device
02/15/2006CN1241641C Toxoplasma body, rubella, giant cell, herpes-I and-II virs antigen purifying technique
02/14/2006US6999905 Method for extracting significant signal, recording medium and program
02/14/2006US6999810 Biosensor and methods of use thereof
02/14/2006US6999175 Analytical method and apparatus
02/14/2006US6998596 Imaging system for examining biological material
02/14/2006US6998559 Detection system for sorting apparatus
02/14/2006US6998472 Obesity gene
02/14/2006US6998468 Anti-C2/C2a inhibitors of complement activation
02/14/2006US6998396 measuring catalytic iron content in urine in a human afflicted with a progressive kidney disease and administering an iron chelator such as deferiprone; method can include measuring total urinary protein content, blood urea nitrogen, or creatinine
02/14/2006US6998274 Composite arrays utilizing microspheres
02/14/2006US6998273 Collection device for lateral flow chromatography
02/14/2006US6998272 used as scaffolds in the combinatorial synthesis of receptor molecules; solid phase synthesis
02/14/2006US6998254 Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis
02/14/2006US6998251 Arrays for use in high throughput assays, organic synthesis and combinatorial chemistry; microfluidics
02/14/2006US6998249 conducting at least three distinct assays in parallel to provide information about three distinct parameters of cytotoxicity of a chemical in a given target cell, which information is useful for predicting in vivo cytotoxicity
02/14/2006US6998248 a porous matrix; an analyte oxidation signal producing system; an hemolyzing agent for producing hemosylate in the sample, at least one of: (i) a means for obtaining the physiological sample; and (ii) an analyte standard
02/14/2006US6998246 Detecting an analyte in a sample using analyte-specific conjugates which have at least one heterologous group for an analyte-independent binding to a control zone
02/14/2006US6998245 Serine protease BSSP5
02/14/2006US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist
02/14/2006US6998243 Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
02/14/2006US6998242 Method of diagnosing metabolic bone diseases
02/14/2006US6998241 For use in sandwich immunoassays; kits
02/14/2006US6998240 Screen for selective inhibitors or activators of Smad protein function
02/14/2006US6998239 contacting an isolated or recombinant CCX CKR polypeptide or, a fragment or variant, and the chemokine in the presence of a test compound, comparing the level of binding of the chemokine and the polypeptide
02/14/2006US6998238 Method for determining MIF content
02/14/2006US6998236 Methods for detecting interaction between a test moiety and a plurality of target moieties
02/14/2006US6998234 Determining gene expression profile of vascular endothelial cells; obtain cells, incubate with immunological agent, isolate bound cells, extract ribonucleic acid sequences, expose to probe, monitor expression profile
02/14/2006US6998233 Methods for ligand discovery
02/14/2006US6998232 determining, in a sample from a human subject, the level of expression of at least two polynucleotides, wherein a higher level of expression of the polynucleotides compared to cancer free human polynucleotide expression is an indication of cancer
02/14/2006US6998231 Coding or classification of prion sample; obtain sample, monitor physical properties of sample, compare to control
02/14/2006US6998228 Generation of solid support for use in the detection of preferential targets in sample; obtain surface, deposit preferential material on surface, form support
02/14/2006US6998123 interleukins (IL-11); fibronectins; glycoproteins
02/14/2006US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides
02/14/2006US6998107 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography
02/14/2006US6998055 Concentration device using magnetic particles and method therefor
02/14/2006US6998021 Arrangement for paper machine, and blow box
02/14/2006US6997374 Apparatus for testing for particulate contaminants in depositories for mail-like articles
02/14/2006US6997347 Apparatus and method for generating calibration gas
02/14/2006US6997344 Automated mechanical mechanism for a blood glucose sensor dispensing instrument
02/14/2006US6997343 Sensor dispensing device
02/14/2006US6997089 Optical grading system for slicer apparatus
02/14/2006US6997071 Non-destructive method of predicting performance of ceramic components
02/14/2006US6997045 Rheomixer device
02/14/2006US6997039 Carbon nanotube based resonant-circuit sensor
02/14/2006US6997038 Gas sensor having improved structure for installation of protective cover
02/14/2006US6997037 Determination of effective composition of a mixture of hydrocarbon gases
02/14/2006US6997035 Method and device for evaluating restitution characteristics of a golf club head
02/14/2006CA2394900C Diabetes management system
02/14/2006CA2384170C Cgmp-visualizing probe and method of detecting and quantifying cgmp by using the same
02/14/2006CA2286195C Method and devices for partitioning biological sample liquids into microvolumes
02/14/2006CA2217476C Method and apparatus for quantitative particle determination in fluids
02/14/2006CA2198470C Luciferase labelling method
02/09/2006WO2006015383A2 Biomarkers for diagnosis, prognosis, monitoring, and treatment decisions for drug resistance and sensitivity
02/09/2006WO2006015365A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof
02/09/2006WO2006015174A2 Detection of truncation mutations by mass spectrometry
02/09/2006WO2006015098A2 Taxol immunoassay
02/09/2006WO2006014876A1 Methods of diagnosing alzheimer's disease
02/09/2006WO2006014800A1 Methods for determining the origin of sucralose products
02/09/2006WO2006014680A1 Methods and devices for analyte detection
02/09/2006WO2006014638A2 ANTIBODIES TO CROSS-LINKED AMYLOID β OLIGOMERS
02/09/2006WO2006014576A2 Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals
02/09/2006WO2006014505A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
02/09/2006WO2006014437A2 Methods and systems for nanoparticle enhancement of signals
02/09/2006WO2006014351A2 Exploring fluorophore microenvironments
02/09/2006WO2006014335A2 Compositions and methods for treatment of non-hodgkin’s lymphoma
02/09/2006WO2006013921A1 Reagent containing protease reaction promoter and/or colorant stabilizer
02/09/2006WO2006013474A2 Ppgalnac-t6 mrna or peptide as a new marker for detection cancer cells
02/09/2006WO2006013472A2 Novel anti-igf-ir antibodies and uses thereof
02/09/2006WO2006013354A1 Method for determining the selectivity of a pre-synaptic neuromuscular blocking substance
02/09/2006WO2006013336A1 Hpv vaccine comprising peptides from host cell proteins
02/09/2006WO2006013329A1 Assay device & method
02/09/2006WO2006013287A1 Optical component for observing a nanometric sample, system comprising same, analysis method using same, and uses thereof
02/09/2006WO2006013109A1 Method for testing a substance interacting with a target molecule